title: A model of chronic nutrient infusion in the rat.
abstract: Chronic exposure to excessive levels of nutrients is postulated to affect the function of several organs and tissues and to contribute to the development of the many complications associated with obesity and the metabolic syndrome, including type 2 diabetes. To study the mechanisms by which excessive levels of glucose and fatty acids affect the pancreatic beta-cell and the secretion of insulin, we have established a chronic nutrient infusion model in the rat. The procedure consists of catheterizing the right jugular vein and left carotid artery under general anesthesia; allowing a 7-day recuperation period; connecting the catheters to the pumps using a swivel and counterweight system that enables the animal to move freely in the cage; and infusing glucose and/or Intralipid (a soybean oil emulsion which generates a mixture of approximately 80% unsaturated/20% saturated fatty acids when infused with heparin) for 72 hr. This model offers several advantages, including the possibility to finely modulate the target levels of circulating glucose and fatty acids; the option to co-infuse pharmacological compounds; and the relatively short time frame as opposed to dietary models. It can be used to examine the mechanisms of nutrient-induced dysfunction in a variety of organs and to test the effectiveness of drugs in this context.
authors: Montreal Diabetes Research Center, CRCHUM.
authors: Grace
authors: G
authors: Fergusson
authors: Mélanie
authors: M
authors: Ethier
authors: Bader
authors: B
authors: Zarrouki
authors: Ghislaine
authors: G
authors: Fontés
authors: Vincent
authors: V
authors: Poitout
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000032:analysis / Q000378:metabolism; D002405:Catheterization, Central Venous / Q000379:methods; D004655:Emulsions / Q000008:administration & dosage; D004750:Enteral Nutrition / Q000009:adverse effects / Q000379:methods*; D005947:Glucose / Q000008:administration & dosage*; D023421:Models, Animal; D010743:Phospholipids / Q000008:administration & dosage* / Q000097:blood; D051381:Rats; D013024:Soybean Oil / Q000008:administration & dosage* / Q000097:blood
chemical_list: D001786:Blood Glucose; D004655:Emulsions; D010743:Phospholipids; C545823:soybean oil, phospholipid emulsion; D013024:Soybean Oil; D005947:Glucose
references: J Biol Chem. 2001 Sep 21;276(38):35375-81
references: 11457846
references: Biochim Biophys Acta. 2010 Mar;1801(3):289-98
references: 19715772
references: Diabetes Res Clin Pract. 2010 Mar;87(3):322-8
references: 20092903
references: Endocr Rev. 2008 May;29(3):351-66
references: 18048763
references: Diabetologia. 2012 May;55(5):1366-79
references: 22396011
references: Am J Physiol Endocrinol Metab. 2007 Feb;292(2):E549-60
references: 17003242
references: Nat Rev Genet. 2005 Mar;6(3):221-34
references: 15703762
references: Diabetes. 2007 Jul;56(7):1792-801
references: 17400928
references: Diabetologia. 2010 Oct;53(10):2177-87
references: 20596694
references: Am J Physiol. 1997 Jul;273(1 Pt 1):E1-9
references: 9252473
references: Endocrinology. 2003 Dec;144(12):5159-65
references: 12960011
references: Gastroenterology. 2012 Apr;142(4):711-725.e6
references: 22326434
references: Diabetologia. 2010 Nov;53(11):2369-79
references: 20628728
references: J Mol Cell Cardiol. 2013 Feb;55:130-8
references: 22728216
references: Diabetes. 2008 Feb;57(2):424-31
references: 17991758
references: Diabetes. 2012 Mar;61(3):632-41
references: 22338094
references: Lipids. 1996 Nov;31(11):1141-9
references: 8934446
references: J Clin Invest. 1996 Jun 15;97(12):2728-35
references: 8675683
references: Am J Physiol. 1991 Mar;260(3 Pt 1):E353-62
references: 1900667
references: Diabetes. 2010 Sep;59(9):2178-87
references: 20547980
references: Curr Opin Clin Nutr Metab Care. 2010 Jul;13(4):382-90
references: 20495453
references: Diabetes. 2001 Nov;50(11):2481-6
references: 11679425
references: Diabetes. 1987 Apr;36(4):459-64
references: 3545946